HSBC stocks jump – is its cost-cutting plan already paying off?
HSBC's reorganisation has left questions unanswered, but otherwise the banking sector is in robust health
HSBC’s shares bounced this week after the latest results showed the bank had lifted pre-tax profits by 11% in the third quarter, “significantly beating downbeat expectations”, says Patrick Hosking in The Times. The bank said this was due to “strong performances in wealth, personal banking and parts of the investment banking division”. HSBC also promised a further $4.8 billion in distributions to shareholders through buybacks and dividends. CEO Georges Elhedery reaffirmed his plans to winnow out senior ranks of the bank “at pace”, though he “emphatically” ruled out any break-up of the group.
HSBC’s latest good results have certainly cheered shareholders, say Selena Li and Lawrence White on Reuters – the shares are now at a six-year high. However, experts still warn HSBC still “needs to explain more about the financial implications of its overhaul”, which involves merging divisions as well as dividing management along East-West lines. Elhedery has declined to comment on how much the revamp will save the bank in costs, or how many senior roles may be cut. Instead, he argues that any cost savings will be an “ancillary benefit” from simplifying the management of the bank and removing duplication of roles.
Elhedery is right to be cautious about costs, says Lex in the Financial Times. Any saving from cutting HSBC’s “expensive layer of senior bankers” is going to be limited. Even the purported figure of $300 million looks small in comparison to the $3.8 billion of bonuses it handed out in 2023. Similarly, while separating Asian from Western operations may sound logical, a large chunk of the money it makes in the region “comes from deals that originate overseas from international clients”. Overall, there is a very real risk that Elhedery’s plans end up being one of those “grand global restructuring announcements” that HSBC has made many times before.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
What is the state of Britain's other banks?
It’s been a “pretty decent earnings season all round” for the UK banking sector, says AJ Bell’s Russ Mould. NatWest, Lloyds and Barclays all revealed unexpectedly high profits, too. Considering the tougher environment of “falling interest rates and softening economic growth”, shareholders should be “more than satisfied”. Meanwhile, “the absence of any signs of stress among their core customer base” also bodes well.
Perhaps the only cloud on the horizon is the Court of Appeal’s ruling in favour of a claimant who sued Close Brothers over the failure to disclose commissions paid to car deals for car loans, says Hargreaves Lansdown’s Matt Britzman. This suggests that the Financial Conduct Authority (FCA), the City regulator, could take a “harsher view” in its wider investigation into motor finance commissions. If upheld, the verdict would hit Lloyds particularly hard, with a total liability of up to £2 billion, though even then the broader Lloyds investment case “looks solid”.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
How small businesses can take advantage of new sources of finance
Small business Banks have reduced lending to small companies, but there are alternatives as the finance market continues to evolve
By David Prosser Published
-
Do we need central banks, or is it time to privatise money?
Analysis Free banking is one alternative to central banks, but would switching to a radical new system be worth the risk?
By Stuart Watkins Published
-
Byju’s – the startling rise and fall
India’s educational technology start-up Byju's attracted big-name backers and soared to vertiginous heights during Covid. It has now plummeted. What happened?
By Jane Lewis Published
-
A bull market on borrowed time
While the US enjoys a bull market, it may not last. Will the US rate cut push stock prices down?
By Alex Rankine Published
-
What will a broken-up Google look like?
The US courts have ruled that Google is a monopoly, leaving it facing the prospect of a break-up. WIll that be a good thing?
By Matthew Lynn Published
-
How will the UK gambling sector be hit by the Budget?
There are concerns for the UK gambling sector in the lead-up to the Autumn Budget. What could be on the cards?
By Dr Matthew Partridge Published
-
HSBC returns to cost-cutting plan
HSBC is set to revamp its commercial banking division – but will it come at a cost?
By Dr Matthew Partridge Published
-
Pfizer shares rise as US investor takes $1 billion stake
Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic options appear limited
By Dr Matthew Partridge Published
-
Qualcomm could acquire rival Intel – but securing the deal won't be easy
A tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
By Dr Matthew Partridge Published
-
How to invest in the quiet market months
Here's how to invest in the quiet market months, since “sell in May” hasn’t paid off this year.
By Cris Sholto Heaton Published